FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Denies Novo Nordisk Petion on Liraglutide ANDAs

FDA denies a 10/2017 Novo Nordisk petition asking it not to approve any ANDA referencing any of the companys liraglutide-containing drugs as the refer...

Human Drugs

Info Collection Extension on Biologic Safety Reporting

Federal Register notice: FDA sends to OMB an information collection extension for Adverse Experience Reporting (AER) for Licensed Biological Products;...

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 1/5/2018.

Human Drugs

Gottlieb Expects Improvements in PR Drug Supplies

FDA commissioner Scott Gottlieb says production of critically needed drugs in Puerto Rico is improving and shortages may soon begin to ease.

Human Drugs

FDA Approves Amgen sBLA for Xgeva

FDA approves an Amgen supplemental BLA for Xgeva (denosumab) to expand the currently approved indication for the prevention of skeletal-related events...

Medical Devices

BioCardia Files IDE for CardiAMP in Myocardial Ischemia

BioCardia files an IDE for the CardiAMP Chronic Myocardial Ischemia Trial to treat patients with refractory angina.

Medical Devices

FDA Approves Roches Plasma Separation Card

FDA approves Roches cobas Plasma Separation Card, a sample collection device for HIV plasma viral load testing.

Medical Devices

FDA Clears Mevion Medical Systems Proton Therapy

FDA clears a Mevion Medical Systems 510(k) clearance for the Mevion S250i Proton Therapy System that uses its Hyperscan pencil beam scanning technolog...

Human Drugs

J&J Collaborations on Alzheimers, Throat Cancers, etc.

Johnson & Johnson Innovation enters into more than a dozen new product collaborations to address areas of high unmet medical need.

Federal Register

Absorbable Perirectal Spacer Into Class 2

Federal Register notice: FDA classifies the absorbable perirectal spacer into Class 2 (special controls).